PMGC (NASDAQ:ELAB – Get Free Report) released its quarterly earnings data on Monday. The company reported ($52.76) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.30 million for the quarter.
PMGC Price Performance
Shares of NASDAQ ELAB opened at $7.23 on Wednesday. The company has a 50-day moving average price of $8.91 and a 200-day moving average price of $71.85. The stock has a market capitalization of $3.92 million, a P/E ratio of -0.02 and a beta of 1.13. PMGC has a 1 year low of $1.62 and a 1 year high of $466.20.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.
PMGC Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
Further Reading
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
